Chinese Acute Ischemic Stroke Treatment Outcome Registry
- Conditions
- Ischemic Stroke
- Interventions
- Other: treatment following current guideline
- Registration Number
- NCT02470624
- Lead Sponsor
- Peking University First Hospital
- Brief Summary
This is a multi-center registry study. The investigators will include 10,000 patients with confirmed acute ischemic stroke in China. The aim of the study is to survey current treatment situation in China and compare the effectiveness and safety between different intervention regimens.
- Detailed Description
Stroke is a common disease in China. Compared to western countries, there are many treatment regimens used in clinical practice in China. But their treatment effects are not well validated. The aim of the study is to survey current treatment situation in China and compare the effectiveness and safety between different intervention regimens.
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 10000
Inclusion Criteria
- age ≥18 yesrs
- confirmed diagnosis of an ischemic stroke
- admission within 1 week after onset of stroke or within treatment time window for patients of thrombolysis treatment
- signed informed consent
Exclusion Criteria
- with intracerebral hemorrhage
- with severe morbid (estimated survival duration less than 3 months)
- could not provide follow-up information
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description treatment following current guideline treatment following current guideline -
- Primary Outcome Measures
Name Time Method death or severe disability 90 days
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Peking University First Hospital
🇨🇳Beijing, China